.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Baxter
Daiichi Sankyo
McKinsey
Novartis
Teva
Colorcon
Fuji
Covington
Mallinckrodt

Generated: November 17, 2017

DrugPatentWatch Database Preview

Sodium benzoate; sodium phenylacetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium benzoate; sodium phenylacetate and what is the scope of sodium benzoate; sodium phenylacetate patent protection?

Sodium benzoate; sodium phenylacetate
is the generic ingredient in three branded drugs marketed by Maia Pharms Inc, B Braun, Medicis, Navinta Llc, and Ailex Pharms Llc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred drug master file entries for sodium benzoate; sodium phenylacetate. Seven suppliers are listed for this compound.

Summary for sodium benzoate; sodium phenylacetate

Pharmacology for sodium benzoate; sodium phenylacetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ailex Pharms Llc
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)207096-001Feb 24, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Maia Pharms Inc
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)208521-001May 8, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Navinta Llc
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)205880-001Aug 4, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Medicis
AMMONUL
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)020645-001Feb 17, 2005APRXYesYes► Subscribe► Subscribe► Subscribe
B Braun
UCEPHAN
sodium benzoate; sodium phenylacetate
SOLUTION;ORAL019530-001Dec 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sodium benzoate; sodium phenylacetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
B Braun
UCEPHAN
sodium benzoate; sodium phenylacetate
SOLUTION;ORAL019530-001Dec 23, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Julphar
McKesson
Fish and Richardson
Citi
McKinsey
Moodys
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot